Gene · 38
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Allosterically coupled conformational dynamics in solution prepare the sterol transfer protein StarD4 to release its cargo upon interaction with target membranes. | Front Mol Biosci | 2023 | 37275961 | PubTator, text mining | PubMed |
| Identification of host regulators of Mycobacterium tuberculosis phenotypes uncovers a role for the MMGT1-GPR156 lipid droplet axis in persistence. | Cell Host Microbe | 2023 | 37269834 | PubTator, text mining | PubMed |
| An early prediction model for gestational diabetes mellitus based on metabolomic biomarkers. | Diabetol Metab Syndr | 2023 | 37264408 | PubTator, text mining | PubMed |
| Orchestral role of lipid metabolic reprogramming in T-cell malignancy. | Front Oncol | 2023 | 37256177 | PubTator, text mining | PubMed |
| Cellular crosstalk in atherosclerotic plaque microenvironment. | Cell Commun Signal | 2023 | 37254185 | PubTator, text mining | PubMed |
| Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions. | Open Med (Wars) | 2023 | 37251536 | PubTator, text mining | PubMed |
| Integrative analysis reveals marker genes for intestinal mucosa barrier repairing in clinical patients. | iScience | 2023 | 37250791 | PubTator, text mining | PubMed |
| A rising tide lifts all MBOATs: recent progress in structural and functional understanding of membrane bound O-acyltransferases. | Front Physiol | 2023 | 37250116 | PubTator, text mining | PubMed |
| Mechanism of action for small-molecule inhibitors of triacylglycerol synthesis. | Nat Commun | 2023 | 37248213 | PubTator, text mining | PubMed |
| The Role of Bitter Melon in Breast and Gynecological Cancer Prevention and Therapy. | Int J Mol Sci | 2023 | 37240264 | PubTator, text mining | PubMed |
| The Role of Punicalagin and Its Metabolites in Atherosclerosis and Risk Factors Associated with the Disease. | Int J Mol Sci | 2023 | 37239823 | PubTator, text mining | PubMed |
| NAT10, an RNA Cytidine Acetyltransferase, Regulates Ferroptosis in Cancer Cells. | Antioxidants (Basel) | 2023 | 37237981 | PubTator, text mining | PubMed |
| Identification and validation of hub genes and pathways associated with mitochondrial dysfunction in hypertrophy of ligamentum flavum. | Front Genet | 2023 | 37234868 | PubTator, text mining | PubMed |
| Crosstalk between cholesterol metabolism and psoriatic inflammation. | Front Immunol | 2023 | 37234169 | PubTator, text mining | PubMed |
| Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma. | Front Immunol | 2023 | 37234166 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Western Diet-Induced Obesity and Obesity-Related Carcinogenesis-A Narrative Review. | Metabolites | 2023 | 37233716 | PubTator, text mining | PubMed |
| Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis. | Genes Dis | 2023 | 37223526 | PubTator, text mining | PubMed |
Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes. | Front Endocrinol (Lausanne) | 2023 | 37223030 | PubTator, text mining | PubMed |
| A coordinated multiorgan metabolic response contributes to human mitochondrial myopathy. | EMBO Mol Med | 2023 | 37222423 | PubTator, text mining | PubMed |
| Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma. | J Transl Med | 2023 | 37221577 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/38/papers?page=17